Stephanie Fish is an Endocrinology/Metabolic physician. OpenAlex indexes 109 publications with 3,254 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce St
1 Maloney
Philadelphia, PA 191044206
Telephone
215-662-2300Registry record last updated 14 Feb 2011.
Clinical trials
- Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Acella Pharmaceuticals, LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
96.4%l-Thyroxine94.7%Levothyroxine Sodium71%Synthroid28%Levoxyl1%Part D<11 patientsThyroid hormones0.9%Armour Thyroid100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.6%Vitamin D3 Analog3.6%Calcitriol100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Exposure to GLP-1RA and Risk of Structural Progression in Differentiated Thyroid Cancer
The Journal of Clinical Endocrinology & Metabolism
2026 - Bond Ladders—Unlocking Direct Indexing Opportunities in Fixed Income
The Journal of Beta Investment Strategies
2023 - Phase 2 of trametinib plus radioiodine in <i>RAS-</i>mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446).
Journal of Clinical Oncology
2022 - Frequent neck US in papillary thyroid cancer likely detects non‐actionable findings
Clinical Endocrinology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”